Effect of Prophylactic and Therapeutic Anticoagulants in Egyptian Patients With COVID-19

NCT04736901 · clinicaltrials.gov ↗

COMPLETED

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Covid19
Corona Virus Infection
Hypercoagulability

Interventions

DRUG: Enoxaparin
DRUG: Enoxaparin
DRUG: Rivaroxaban
DRUG: Rivaroxaban
DRUG: Apixaban
DRUG: Apixaban

Sponsor

Ain Shams University

Collaborators

[object Object]